Charles Schwab’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,095
Closed -$108K 3666
2024
Q1
$108K Hold
2,095
﹤0.01% 3300
2023
Q4
$148K Hold
2,095
﹤0.01% 3312
2023
Q3
$154K Hold
2,095
﹤0.01% 3321
2023
Q2
$313K Buy
2,095
+1,022
+95% +$141K ﹤0.01% 3217
2023
Q1
$56.9K Sell
1,073
-179
-14% -$10.8K ﹤0.01% 3330
2022
Q4
$115K Buy
1,252
+7
+0.6% +$1.52K ﹤0.01% 3246
2022
Q3
$288K Sell
1,245
-52
-4% -$13K ﹤0.01% 3115
2022
Q2
$242K Buy
+1,297
New +$361K ﹤0.01% 3219

Other funds holding PIII

Charles Schwab's PIII Position: Q2 2024 in Review

Charles Schwab sold out of P3 Health Partners (PIII) in Q2 2024, closing a stake of 2,095 shares — an estimated $108K sold.

Charles Schwab first reported a position in PIII in Q2 2022 and held it in 8 quarters. The position peaked at $313K in Q2 2023. 60 funds tracked by Wall St. Rank hold PIII as of Q2 2024.

  • Charles Schwab reported no remaining P3 Health Partners position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 2,095 P3 Health Partners shares in Q2 2024, an estimated $108K.
  • Charles Schwab first reported a position in P3 Health Partners in Q2 2022 and held it in 8 quarters.
  • Charles Schwab's P3 Health Partners position peaked at $313K in Q2 2023.
  • 60 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.